3 Top Stocks to Buy in July

Real Matters Inc. (TSX:REAL) is one of those stocks that are good buys now as it is seeing strong growth due to low interest rates.

| More on:
Simple life style relaxation with Asian working business woman healthy lifestyle take it easy resting in comfort hotel or home living room having free time with peace of mind and self health balance

Image source: Getty Images

Looking for stocks to buy this month? Here are three suggestions of good stocks to buy now. One is a gold miner, one is in the real estate industry, and the other is a telehealth company.

Eldorado Gold

To protect yourself from the unknown, you should consider buying gold stocks. Eldorado Gold (TSX:ELD)(NYSE:EGO) is a good pick in this sector.

This mid-cap miner has assets in Canada, Turkey, Greece, Romania, and Brazil. Although its share price is not as high as it once was, Eldorado is well positioned to make significant advances in the short term.

The company has strong profit margins and higher three-year revenue and EBITDA growth rates than most miners. The gold miner has managed to cut cost per ounce significantly in recent years. For 2020, revenue is expected to grow by 53%. Earnings are estimated to rise by 2,050%.

Eldorado’s stock is very cheap relative to its future potential growth. Indeed, its five-year PEG is only 0.12.

Eldorado President and CEO George Burns said the company is well-positioned to increase annual gold production to over 500,000 ounces in 2020. This should allow Eldorado to generate significant free cash flow and give the company the opportunity to consider debt reduction later this year.

Real Matters

Real Matters (TSX:REAL) is a network management service provider for the mortgage and insurance industries based in Toronto. Its share price has risen rapidly in the past year-and-a-half. It has more than doubled in value since the start of the year.

Real Matters is benefitting from strong growth in refinance and home purchases volumes in the U.S. mortgage market as rates are very low.

With the U.S. Federal Reserve recently announcing that it will keep its key rate near zero until 2022, the momentum should continue.

The combination of low rates, higher volumes, and market share gains give Real Matters a great risk-reward profile. Strong revenue and profit growth are expected in 2020. Analysts forecast a 44% revenue growth and a 117% earnings growth.

Real Matters’ stock is cheap relative to its future growth with a five-year PEG of 0.63.

WELL Health Technologies

WELL Health Technologies (TSX: WELL) is a Canadian telehealth company. It’s currently the fourth-largest medical clinic operator in Canada and is number one in British Columbia.

Telehealth is just starting across Canada. WELL could potentially be an attractive investment for private equity or big companies like Telus or Loblaw.

WELL has two main businesses: health care clinics and a digital health platform. It has approximately 20 primary care clinics.

WELL launched Virtualclinic+, a telehealth platform, just in time to see COVID-19 hit North America. This platform connects patients to healthcare professionals via video, phone, or secure messaging to limit person-to-person contact. Patients outside of WELL clinics who do not have a doctor can also use the service.

WELL saw its revenue grow by 210% from 2018 to 2019. Revenue growth for the digital health side of the business increased by 920%. A growth of 30% in revenue is expected for 2020. EPS is estimated to grow by 25%.

Telehealth is here to stay, which greatly increases the opportunities for innovation to bridge patient care virtually, where WELL is well positioned to capitalize.

WELL has great opportunities ahead, as it aims to consolidate a fragmented market and revolutionize the healthcare industry in Canada through digital platforms.

Keep reading to discover more top stocks to buy in July.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Stephanie Bedard-Chateauneuf has no position in any of the stocks mentioned.

More on Investing